Universitätsklinikum Schleswig-Holstein (UKSH)

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort (2019) Wu W, Jordan S, Graf N, Pena JDO, Curram J, Allanore Y, Matucci-Cerinic M, et al. Journal article Actual Treatment Options for Giant Cell Arteritis (2019) Moosig F, Schmalzing M, Aries PM, Henes J, Lamprecht P, Rech J, Witte T Journal article Adverse events 2.0-Let us get SERIOs New reporting for adverse event outcomes needed in the era of immunooncology (2019) Heinzerling L, Ascierto PA, Dummer R, Gogas H, Grob JJ, Lebbe C, Long GV, et al. Journal article, Letter First real-world insights on benefit of apremilast treatment in patients with moderate to severe psoriasis after switching from fumaric acid esters from the APART Study - an interim analysis (2019) Mrowietz U, Ertner K, Sticherling M, Grosse V, Popp G, Roemmler-Zehrer J, Lampl M, et al. Conference contribution Preservation of Microvascular Integrity in Murine Orthotopic Tracheal Allografts by Clopidogrel (2019) Heim C, Khan MA, von Silva-Tarouca B, Kuckhahn A, Stamminger T, Ramsperger-Gleixner M, Nicolls MR, et al. Journal article Clotting factor activity in fresh frozen plasma after thawing with a new radio wave thawing device (2019) Kuta P, Melling N, Zimmermann R, Achenbach S, Eckstein R, Strobel J Journal article Topical therapy of psoriasis vulgaris - a treatment pathway (2019) Koerber A, Wilsmann-Theis D, Augustin M, Von Kiedrowski R, Mrowietz U, Rosenbach T, Meller S, et al. Journal article European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis (2019) Oosterhaven JAF, Uter W, Aberer W, Armario-Hita JC, Ballmer-Weber BK, Bauer A, Czarnecka-Operacz M, et al. Journal article Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark (2019) Brinker TJ, Hekler A, Hauschild A, Berking C, Schilling B, Enk AH, Haferkamp S, et al. Journal article A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA) (2019) Bischoff J, Barinoff J, Mundhenke C, Bauerschlag DO, Costa SD, Herr D, Luebbe K, et al. Journal article